Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H et al (2021) Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature. https://doi.org/10.1038/s41586-021-04387-1
Article
PubMed
PubMed Central
Google Scholar
Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J et al (2021) Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. https://doi.org/10.1038/s41586-021-04389-z
Article
PubMed
Google Scholar
Schmidt F, Weisblum Y, Rutkowska M, Poston D, DaSilva J, Zhang F et al (2021) High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape. Nature 600(7889):512–516. https://doi.org/10.1038/s41586-021-04005-0
CAS
Article
PubMed
Google Scholar
Gruell H, Vanshylla K, Tober-Lau P, Hillus D, Schommers P, Lehmann C et al (2022) mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nat Med. https://doi.org/10.1038/s41591-021-01676-0
Article
PubMed
PubMed Central
Google Scholar
Wratil PR, Stern M, Priller A, Willmann A, Almanzar G, Vogel E et al (2022) Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat Med. https://doi.org/10.1038/s41591-022-01715-4
Article
PubMed
Google Scholar
Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L et al (2021) Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 593(7858):266–269. https://doi.org/10.1038/s41586-021-03470-x
CAS
Article
PubMed
Google Scholar
Hay JA, Kissler SM, Fauver JR, Mack C, Tai CG, Samant RM et al (2022) Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant. medRxiv. https://doi.org/10.1101/2022.01.13.22269257
Article
Google Scholar
Petros BA, Turcinovic J, Welch NL, White LF, Kolaczyk ED, Bauer MR et al (2022) Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations. medRxiv. https://doi.org/10.1101/2022.01.27.22269787
Article
Google Scholar
Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A et al (2022) Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron. medRxiv. https://doi.org/10.1101/2022.01.10.22269010
Article
Google Scholar
Araf Y, Akter F, Tang Y-D, Fatemi R, Parvez MSA, Zheng C et al (2022) Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol. https://doi.org/10.1002/jmv.27588
Article
PubMed
PubMed Central
Google Scholar
Karim SSA, Karim QA (2021) Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet 398(10317):2126–2128. https://doi.org/10.1016/s0140-6736(21)02758-6 ((Epub 2021/12/07))
CAS
Article
PubMed
PubMed Central
Google Scholar
Mohapatra RK, Sarangi AK, Kandi V, Azam M, Tiwari R, Dhama K (2022) Omicron (B1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario. J Med Virol. https://doi.org/10.1002/jmv.27561
Article
PubMed
PubMed Central
Google Scholar
Alaa Abdel Latif JLM, Manar A, Ginger T, Marco C, Emily H, Jerry Z, Mark Z, Emory H, Nate M, Chunlei W, Kristian GA, Andrew IS, Karthik G, Laura DH, and the Center for Viral Systems Biology. http://outbreak.info. Acccessed 22 Jul 2021
Bekliz M, Adea K, Alvarez C, Essaidi-Laziosi M, Escadafal C, Kaiser L et al (2021) Analytical sensitivity of seven SARS-CoV-2 antigen-detecting rapid tests for Omicron variant. medRxiv. https://doi.org/10.1101/2021.12.18.21268018
Article
Google Scholar
Bekliz M, Adea K, Essaidi-Laziosi M, Sacks JA, Escadafal C, Kaiser L et al (2021) SARS-CoV-2 rapid diagnostic tests for emerging variants. Lancet Microbe 2(8):e351. https://doi.org/10.1016/S2666-5247(21)00147-6
CAS
Article
PubMed
PubMed Central
Google Scholar
Corman VM, Haage VC, Bleicker T, Schmidt ML, Mühlemann B, Zuchowski M et al (2021) Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. Lancet Microbe 2(7):e311–e319. https://doi.org/10.1016/S2666-5247(21)00056-2
CAS
Article
PubMed
PubMed Central
Google Scholar
Jungnick S, Hobmaier B, Mautner L, Hoyos M, Haase M, Baiker A et al (2021) In vitro rapid antigen test performance with the SARS-CoV-2 variants of concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta). Microorganisms 9(9):1967. https://doi.org/10.3390/microorganisms9091967
CAS
Article
PubMed
PubMed Central
Google Scholar
Osterman A, Baldauf HM, Eletreby M, Wettengel JM, Afridi SQ, Fuchs T et al (2021) Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. Med Microbiol Immunol 210(1):65–72. https://doi.org/10.1007/s00430-020-00698-8 ((Epub 2021/01/17))
CAS
Article
PubMed
PubMed Central
Google Scholar
Osterman A, Iglhaut M, Lehner A, Späth P, Stern M, Autenrieth H et al (2021) Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern. Med Microbiol Immunol 210(5–6):263–275. https://doi.org/10.1007/s00430-021-00719-0 ((Epub 2021/08/21))
CAS
Article
PubMed
PubMed Central
Google Scholar
Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Kawaoka Y (2021) Comparative sensitivity of rapid antigen tests for the delta variant (B.1.617.2) of SARS-CoV-2. Viruses 13(11):2183. https://doi.org/10.3390/v13112183
CAS
Article
PubMed
PubMed Central
Google Scholar
Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C et al (2021) Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill 26:44. https://doi.org/10.2807/1560-7917.Es.2021.26.44.2100441 ((Epub 2021/11/06))
Article
Google Scholar
Schildgen V, Demuth S, Lüsebrink J, Schildgen O (2021) Limits and opportunities of SARS-CoV-2 antigen rapid tests: an experienced-based perspective. Pathogens 10:1. https://doi.org/10.3390/PATHOGENS10010038 ((Epub 2021/01/21))
Article
Google Scholar
Toptan T, Eckermann L, Pfeiffer AE, Hoehl S, Ciesek S, Drosten C et al (2021) Evaluation of a SARS-CoV-2 rapid antigen test: potential to help reduce community spread? J Clin Virol 135:104713. https://doi.org/10.1016/j.jcv.2020.104713 ((Epub 2020/12/23))
CAS
Article
PubMed
Google Scholar
Bekliz M, Adea K, Essaidi-Laziosi M, Sacks JA, Escadafal C, Kaiser L et al (2022) SARS-CoV-2 antigen-detecting rapid tests for the delta variant. Lancet Microbe 3(2):e90. https://doi.org/10.1016/S2666-5247(21)00302-5
CAS
Article
PubMed
Google Scholar
Krüger LJ, Tanuri A, Lindner AK, Gaeddert M, Köppel L, Tobian F et al (2022) Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: a multi-centre clinical evaluation. EBioMedicine 75:103774. https://doi.org/10.1016/j.ebiom.2021.103774 ((Epub 2021/12/28))
CAS
Article
PubMed
Google Scholar
Dinnes J, Deeks JJ, Berhane S, Taylor M, Adriano A, Davenport C et al (2021) Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD013705.pub2
Article
PubMed
PubMed Central
Google Scholar
Adamson B, Sikka R, Wyllie AL, Premsrirut P (2022) Discordant SARS-CoV-2 PCR and rapid antigen test results when infectious: a December 2021 occupational case series. medRxiv. https://doi.org/10.1101/2022.01.04.22268770
Article
Google Scholar
Schrom J, Marquez C, Pilarowski G, Wang G, Mitchell A, Puccinelli R et al (2022) Direct comparison of SARS Co-V-2 nasal RT-PCR and rapid antigen test (BinaxNOW™) at a community testing site during an Omicron surge. medRxiv. https://doi.org/10.1101/2022.01.08.22268954
Article
Google Scholar
Deerain J, Druce J, Tran T, Batty M, Yoga Y, Fennell M et al (2021) Assessment of the analytical sensitivity of ten lateral flow devices against the SARS-CoV-2 omicron variant. J Clin Microbiol. https://doi.org/10.1128/jcm.02479-21 ((Epub 2021/12/23))
Article
PubMed
Google Scholar
European Commission. EU health preparedness: A common list of COVID-19 rapid antigen tests; A common standardised set of data to be included in COVID-9 test result certificates; and A common list of COVID-19 laboratory based antigenic assays. https://ec.europa.eu/health/system/files/2022-01/covid-19_rat_common-list_en.pdf. Accessed 07 Jul 2022
Centers for Disease Control and Prevention (CDC) Information for laboratories about coronavirus (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/lab/index.html. Accessed 2 Jul 2022
Dächert C, Muenchhoff M, Graf A, Autenrieth H, Bender S, Mairhofer H et al (2022) Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants. Med Microbiol Immunol. https://doi.org/10.1007/s00430-022-00728-7 ((Epub 2022/01/22))
Article
PubMed
PubMed Central
Google Scholar
Weinberger T, Steffen J, Osterman A, Mueller TT, Muenchhoff M, Wratil PR et al (2021) Prospective longitudinal serosurvey of healthcare workers in the first wave of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in a quaternary care hospital in Munich, Germany. Clin Infect Dis 73(9):e3055–e3065. https://doi.org/10.1093/cid/ciaa1935 ((Epub 2021/01/04))
CAS
Article
PubMed
Google Scholar
Kannan SR, Spratt AN, Cohen AR, Naqvi SH, Chand HS, Quinn TP et al (2021) Evolutionary analysis of the delta and delta plus variants of the SARS-CoV-2 viruses. J Autoimmun 124:102715. https://doi.org/10.1016/j.jaut.2021.102715 ((Epub 2021/08/11))
CAS
Article
PubMed
PubMed Central
Google Scholar
Stanley S, Hamel DJ, Wolf ID, Riedel S, Dutta S, Cheng A et al (2022) Limit of detection for rapid antigen testing of the SARS-CoV-2 Omicron variant. medRxiv. https://doi.org/10.1101/2022.01.28.22269968
Article
Google Scholar
Puyskens A, Krause E, Michel J, Nübling CM, Scheiblauer H, Bourquain D et al (2021) Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill 26:44. https://doi.org/10.2807/1560-7917.Es.2021.26.44.2100442 ((Epub 2021/11/06))
Article
Google Scholar
Klein S, Cortese M, Winter SL, Wachsmuth-Melm M, Neufeldt CJ, Cerikan B et al (2020) SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. Nat Commun 11(1):5885. https://doi.org/10.1038/s41467-020-19619-7
CAS
Article
PubMed
PubMed Central
Google Scholar
Liu T, Jia P, Fang B, Zhao Z (2020) Differential expression of viral transcripts from single-cell RNA sequencing of moderate and severe COVID-19 patients and its implications for case severity. Front Microbiol. https://doi.org/10.3389/fmicb.2020.603509
Article
PubMed
PubMed Central
Google Scholar
Paul-Ehrlich-Institute. SARS-CoV-2-Antigentests für Nachweis der Omikron-Infektion geeignet (in German). https://www.pei.de/DE/newsroom/hp-meldungen/2021/211230-antigentests-omikron-variante.html. Accessed 2 Jul 2022
Gesundheitministerium für Gesundheit. Fragen und Antworten zu Quarantäne- und Isolierungsregeln (in German). https://www.bundesgesundheitsministerium.de/coronavirus/faq-quarantaene-isolierungsregeln.html#c23632. Accessed 2 Jul 2022
Bundesinstitut für Arzneimittel und Medizinprodukte (BfarM). Antigen-Tests auf SARS-CoV-2 zur Eigenanwendung, die Gegenstand des Anspruchs nach §1 Satz 1 Coronavirus-Testverordnung (TestV) sind („Selbsttests“) (in German). https://antigentest.bfarm.de/ords/f?p=ANTIGENTESTS-AUF-SARS-COV-2:TESTS-ZUR-EIGENANWENDUNG-DURCH-LAIEN:11537849404532:::::&tz=1:00. Accessed 2 Jun 2022
Lin J, Yan K, Zhang J, Cai T, Zheng J (2020) A super-spreader of COVID-19 in Ningbo city in China. J Infect Public Health 13(7):935–937. https://doi.org/10.1016/j.jiph.2020.05.023
Article
PubMed
PubMed Central
Google Scholar
Liu L-T, Tsai J-J, Chen C-H, Lin P-C, Tsai C-Y, Tsai Y-Y et al (2022) Isolation and identification of a rare spike gene double-deletion SARS-CoV-2 variant from the patient with high cycle threshold value. Front Med. https://doi.org/10.3389/fmed.2021.822633
Article
PubMed
PubMed Central
Google Scholar
Singanayagam A, Patel M, Charlett A, Lopez Bernal J, Saliba V, Ellis J et al (2020) Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill 25:32. https://doi.org/10.2807/1560-7917.Es.2020.25.32.2001483 ((Epub 2020/08/15))
Article
Google Scholar
Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N et al (2020) Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci 117(28):16587–16595. https://doi.org/10.1073/pnas.2009799117
CAS
Article
PubMed
PubMed Central
Google Scholar
Popa A, Genger J-W, Nicholson MD, Penz T, Schmid D, Aberle SW et al (2020) Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med 12(573):eabe2555. https://doi.org/10.1126/scitranslmed.abe2555
CAS
Article
PubMed
PubMed Central
Google Scholar
Ito K, Piantham C, Nishiura H (2021) Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark. J Med Virol. https://doi.org/10.1002/jmv.27560 ((Epub 2021/12/31))
Article
PubMed
PubMed Central
Google Scholar
Nishiura H, Ito K, Anzai A, Kobayashi T, Piantham C, Rodríguez-Morales AJ (2021) Relative reproduction number of SARS-CoV-2 Omicron (B.1.1.529) compared with delta variant in South Africa. J Clin Med 11:1. https://doi.org/10.3390/jcm11010030 ((Epub 2022/01/12))
CAS
Article
Google Scholar
Petersen I, Crozier A, Buchan I, Mina MJ, Bartlett JW (2021) Recalibrating SARS-CoV-2 antigen rapid lateral flow test relative sensitivity from validation studies to absolute sensitivity for indicating individuals shedding transmissible virus. Clin Epidemiol 13:935–940. https://doi.org/10.2147/clep.S311977 ((Epub 2021/10/28))
Article
PubMed
PubMed Central
Google Scholar
Ben K, Alex M, Mariya K, Alison B, Niluka G, Jie Z et al (2022). Nat Portfolio. https://doi.org/10.21203/rs.3.rs-1121993/v1
Article
Google Scholar
Paul-Ehrlich-Institute. Mindestkriterien für SARS-CoV-2 Antigentests im Sinne von § 1 Abs. 1 Satz 1 TestVO: antigenschnelltests (in German). https://www.pei.de/SharedDocs/Downloads/DE/newsroom/dossiers/mindestkriterien-sars-cov-2-antigentests-01-12-2020.pdf?__blob=publicationFile. Accessed 2 Jul 2022.
World Health Organization (WHO) (2020) Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays. Accessed 2 Jul 2022